A part of Watch Media

MedWatchTuesday3 October 2023

  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
MedWatchTuesday3 October 2023
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
Hearing health

Italian hearing aid retailer expects first OTC products in 2022

In the second half of next year, Amplifon expects to see the first over-the-counter products on the US market.
Photo: JOHN GRESS/REUTERS / X01637
Photo: JOHN GRESS/REUTERS / X01637
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN

Amplifon, a large Italian retailer of hearing aids, is expecting its first marketed products to be sold without a prescription in the US during the second half of 2022, the company revealed during its capital markets day on Monday.

The hearing healthcare company's expectation is that the proposed regulations on the OTC market, which would enable over-the-counter sales of hearing aids to adults with mild to moderate hearing loss – sidestepping an appointment with an audiologist – willl be presented by the US Food and Drug Administration (FDA) in November.

Hereafter, there will be a short window for industry objections and recommendations, before approximately six months of implementation commence.

The timeline therefore fits with the executive order that President Joe Biden signed at the beginning of July, which sent ripples through the hearing aid market.

In the order, Biden criticized the prices of hearing aids, which he thinks have become too expensive for US families. He therefore directed the FDA to propose rules for the over-the-counter sales of hearing aids within 120 days.

Italian hearing aid retailer disappoints with growth prognosis

New GN device to open giant market for mild hearing loss 

Hearing industry challenger applauds Biden's price battle

New Biden order criticizing hearing aid expense causes falling share prices 

Share article

Related articles:

  • Photo: Eargo / PR

    Hearing industry challenger applauds Biden's price battle

    For subscribers

  • Photo: Demant / PR

    New Biden order criticizing hearing aid expense causes falling share prices

    For subscribers

  • Photo: GN / PR

    New GN device to open giant market for mild hearing loss

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Foto: Yuriko Nakao/Reuters/Ritzau Scanpix
Medtech

Olympus appoints new chief medical officer

The new medical director is brought in from Medtronic. 
  • Olympus ramps up digital ambitions after AI endoscopy acquisition
  • Olympus to acquire AI endoscopy startup

For subscribers



Foto: Tom Little
Pharma & biotech

FDA approves Novo Nordisk drug to treat rare condition

For subscribers



Fujifilm Diosynth Biotechnologies' factory in Hillerød, Denmark. | Foto: Liselotte Plenov / Fotorummet / Pr
Pharma & biotech

Fujifilm expands management with former Leo executive

For subscribers


Foto: Andrew Kelly/Reuters/Ritzau Scanpix
Pharma & biotech

Low share price may knock Galecto off the stock exchange

For subscribers


Foto: Mike Segar/Reuters/Ritzau Scanpix
Pharma & biotech

Snack maker keeps an eye on Novo Nordisk's obesity drug


Foto: Alexander Heinl/AP/Ritzau Scanpix
Pharma & biotech

Novo Nordisk's semaglutide to be studied for positive effect on alcoholics

For subscribers


  • Vaccine breakthrough behind mRNA shots wins Nobel Prize

    The two scientists will share the 11 million-krona ( USD 1 million) award, the Nobel Assembly at the Karolinska Institutet in Stockholm said in a statement Monday.

    For subscribers


  • Foto: Ws Audiology / Pr

    WS Audiology hires new chief technology officer from car manufacturer

    He succeeds chief research & development officer Stefan Menzl, who is stepping down after six years.

    For subscribers


  • Foto: Tom Little

    Novo Nordisk files lawsuit against US authorities ahead of price negotiation

    The litigation is the latest in a long line of industry lawsuits related to price negotiations.

    For subscribers


  • Foto: Mike Segar

    FDA rejects atopic dermatitis drug lebrikizumab

    Eli Lilly had expected a launch this year.

    For subscribers


  • The FDA has updated the package label of Novo Nordisk's diabetes drug, Ozempic, with a warning about intestinal blockage disorder as a possible side effect. | Foto: Tom Little/Reuters/Ritzau Scanpix

    FDA updates Novo Nordisk's Ozempic drug label with side effect alert

    The diabetes drug might cause a potentially fatal intestinal blockage, the authorities warn.

    For subscribers


  • Foto: Anushree Fadnavis/Reuters/Ritzau Scanpix

    Country Manager: Indians will have to wait for Wegovy until 2026

    Up to 40% of the female population aged 30-49 in India is overweight.

    For subscribers


Further reading

Foto: Tom Little
Pharma & biotech

FDA approves Novo Nordisk drug to treat rare condition

The marketing authorization applies to children and adolescents aged 9 years and older, as well as adults with ”relatively” preserved kidney functions.

For subscribers



Fujifilm Diosynth Biotechnologies' factory in Hillerød, Denmark. | Foto: Liselotte Plenov / Fotorummet / Pr
Pharma & biotech

Fujifilm expands management with former Leo executive

The contract manufacturer has hired a chief people officer with immediate effect.

For subscribers



Foto: Mike Segar/Reuters/Ritzau Scanpix
Pharma & biotech

Snack maker keeps an eye on Novo Nordisk's obesity drug

”As with anything that could potentially impact our business, we’re looking at it,” says the former Kellogg’s CEO.

Foto: Alexander Heinl/AP/Ritzau Scanpix
Pharma & biotech

Novo Nordisk's semaglutide to be studied for positive effect on alcoholics

Previous studies have shown that alcohol cravings disappeared when people were treated with GLP-1 agonist exanatide.

For subscribers



Genmab CEO Jan van de Winkel and director general of The Confederation of Danish Industry, Lars Sandahl Sørensen. | Photo: Genmab / PR
Pharma & biotech

Genmab has officially opened its new headquarters

The CEO describes the new premises as a symbol of the company’s commitment to advancing science and innovation.

For subscribers



Foto: Yuriko Nakao/Reuters/Ritzau Scanpix
Medtech

Olympus appoints new chief medical officer

The new medical director is brought in from Medtronic. 

For subscribers


Jobs

  • Scientist - Bioanalysis, Biologics

  • Global Medical Manager

  • Supply Value Stream (SVS) Project Manager

  • Senior Legal Councel

  • Director, Head of Antibody Technology

  • VP of Software Development, Perfusion Tech

  • Project Director, HR & ESG

  • QA/RA Manager

  • Audit & Supplier Manager

  • Qualified Person to AJ Vaccines

  • Senior QA Specialists (GMP or GCP)

  • Senior Analytical Scientists

  • Clinical Trial Manager

  • Clinical Supply Manager

  • Senior CMC Specialist, Upstream Processing, Genmab

See all jobs

Latest news

  • Novo Nordisk's semaglutide to be studied for positive effect on alcoholics –
  • Olympus appoints new chief medical officer –
  • Low share price may knock Galecto off the stock exchange –
  • Fujifilm expands management with former Leo executive –
  • Snack maker keeps an eye on Novo Nordisk's obesity drug –
  • FDA approves Novo Nordisk drug to treat rare condition –
  • FDA updates Novo Nordisk's Ozempic drug label with side effect alert –
  • FDA rejects atopic dermatitis drug lebrikizumab –
  • FDA to support new orphan drugs through pilot program –
  • Vaccine breakthrough behind mRNA shots wins Nobel Prize –
See all

Jobs

  • Scientist - Bioanalysis, Biologics

  • Global Medical Manager

  • Supply Value Stream (SVS) Project Manager

  • Senior Legal Councel

  • Director, Head of Antibody Technology

  • VP of Software Development, Perfusion Tech

  • Project Director, HR & ESG

  • QA/RA Manager

  • Audit & Supplier Manager

  • Qualified Person to AJ Vaccines

  • Senior QA Specialists (GMP or GCP)

  • Senior Analytical Scientists

  • Clinical Trial Manager

  • Clinical Supply Manager

  • Senior CMC Specialist, Upstream Processing, Genmab

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

  • About MedWatch

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Banner Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved